HIV Drug Therapy Glasgow 2024, Glasgow, Great Britain, 10-13 November 2024

Poster presentation: 

• Outcomes after the most common cancers in people with HIV  presented by Alisa Timiryasova on behalf of the RESPOND (International Cohort Consortium of Infectious Diseases) and D:A:D (The Data Collection on Adverse Events of Anti-HIV Drugs Study) study groups.POSTER

• Poster presentation:
  Mortality using raltegravir versus other integrase inhibitors in people with HIV in Europe and Australia  presented by Erich Tusch on behalf of the RESPOND study group.POSTER
  
  Poster presentation:
  Prevalence of HIV drug resistance in people newly diagnosed with HIV who have used pre-exposure prophylaxis in Europe: the PrEPaRE study,  presented by Valentina Cambiano on behalf of the RESPOND study group.POSTER
   

• Changes in the ART coverage and viral suppression from 2020 to 2022 in Kyiv, Ukraine presented by Olga Fursa on behalf of the CARE study group.
   

Nordic HIV & Virology Conference 2024, Stockholm, Sweden, 25-27 September 2024

Poster presentation:

• RESPONDing to Comtemporary Challenges for Pople Living with HIV: An Evolving Cohort Collaboration  presented by Bastian Neesgaard on behalf of RESPOND study group.POSTER 

   

    
   

ECCMID 2024, Barcelona, Spain, 27-30 April 2024

Poster presentations:

• Trends in AIDS-defining illnesses among people living with HIV in Europe: results from the EuroSIDA study (2003-2022) presented by Wendy Bannister on behalf of the EuroSIDA Study Group. POSTER

  
   

Conference on Retrovirus and Opportunistic Infections (CROI 2024), Denver, Colorado, USA, 3-6 March 2024

Poster presentations:

• Novel Biomarkers as Determinants of HBsAg Loss in Persons with HIV/HBV on Tenofovir  presented by Lorin Begré on behalf of the EuroSIDA Study Group. POSTER 
   
• Temporal Trends of Cardiovascular Disease Incidence in People with HIV from 2001-2021  presented by Nadine Jaschinski on behalf of the RESPOND Study Group. POSTER  
   
• Increased Cancer Risk With Low CD4 Counts Persists Despite Over 2 Years of Virological Suppression   presented by Jennifer Hoy on behalf of the RESPOND Study Group. POSTER

IWHOD 2024, Vilamoura, Portugal, 21-23 March 2024

Poster presentations:

• Trends in AIDS-defining illnesses among people living with HIV in Europe: results from the EuroSIDA study (2003-2022) presented by Wendy Bannister on behalf of the EuroSIDA Study Group. POSTER